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Due to the high prevalence of food allergic diseases globally there are increasing demands in clinical
practice for managing IgE-mediated conditions. During the last decade, component resolved diagnostics
has been introduced into the ﬁeld of clinical allergology, providing information that cannot be obtained
from extract-based tests. Component resolved data facilitate more precise diagnosis of allergic diseases
and identify sensitizations attributable to cross-reactivity. Furthermore it assists risk assessment in
clinical practice as sensitization to some allergenic molecules is related to persistence of clinical
symptoms and systemic rather than local reactions. The information may also aid the clinician in pre-
scription of oral immunotherapy (OIT) in patients with severe symptoms, and in giving advice on food
allergen avoidance or on the need to perform food challenges. The use of allergen components is rapidly
evolving and increases our possibility to treat food allergic patients with a more individual approach.
Using molecular allergology, we can already now better diagnose, prognose and grade the food allergy. In
summary, daily routine molecular allergy diagnostics offers a number of beneﬁts that give us a higher
diagnostic precision and allow for better management of the patient.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Component resolved diagnosis (CRD) provides a major step in
improving the accuracy of diagnosing IgE-mediated food allergy.
We are living in an era of exciting research and growth in the ﬁeld
of food allergy. With this CRD concept, allergology is experiencing a
technological revolution, which is transforming into a rapid change
in clinical practice. Our traditional way of diagnosing is challenged
by this new concept. Our tools, based on sometimes poorly stan-
dardized and highly variable allergenic preparations becomerres).
ety of Allergology.
rgology. Production and hosting by Elseclearly deﬁned and allow more analyses in depth.1 The ability to
identify and characterize single allergens at a molecular level is
increasing our knowledge as to the mechanism of sensitization to
foods. The increasing availability of food allergen components
allow for a comprehensive review of the pattern of sensitization.
Studies regarding structural similarity between food allergens help
to explain cross-reactivity between allergens which may be clini-
cally relevant. Certain pan allergen molecules can indicate broad
cross-sensitization and underlie particular pollen-food or plant
food syndrome.2
The relatively high prevalence of food allergy has led to
increased diagnostic testing. CRD can be utilized both in the initial
diagnostic workup and to follow speciﬁc IgE levels over time to
determine when patients may be resolving their allergy andvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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can either be measured by simplex or multiplex testing.3
This review is meant to be a general overview of IgE testing for
food allergy with focus on recent advances of component testing.Fig. 1. Tolerance acquisition of hen's egg allergy with aging. White bars represent
number of HE allergy patients and black bars represent number of patients who
tolerated half of whole heated HE. Filled triangles represent rate of tolerance.Egg (Table 1)
Egg white is the most important source of allergens in egg, and
contains almost 80 non-allergenic and allergenic proteins.4 Aller-
gens that have been identiﬁed to be important and for which the
clinician can test are ovomucoid (Gal d 1), ovalbumin (Gal d 2),
ovotransferrin/conalbumin (Gal d 3), and lysozyme (Gal d 4).5
Ovomucoid has been shown to be the dominant allergen in egg
white. It has unique characteristics, such as stability to heating and
cleavage by proteases and it appears to be allergenic in minute
amounts. Ohtani et al. has recently shown that high levels of IgE to
ovomucoid in egg allergic children is associated with delayed
tolerance development (Fig. 1).6 They investigated tolerance
development in a group of 226 Japanese children allergic to hen's
egg and found that those experiencing delayed tolerance de-
velopments had higher IgE levels of ovomucoid compared with
children who developed tolerance early (Fig. 2).
Egg white IgE testing is in general mostly recommended for
primary diagnosis of egg allergy because it combines the most
commonmajor allergens recognized in egg allergy (ovomucoid and
ovalbumin). Molecular diagnosis has been shown to be helpful in a
more ﬁn-tuned diagnosis of egg allergy. Three different clinical
situations can be distinguished. First scenario is when the indi-
vidual is sensitized to egg white but is able to eat egg without
symptoms. Second situation is when the patient is allergic to raw or
partially raw egg only. Thirdly, when the patient is allergic to all
forms of egg, which is the most severe form.
Ando et al. showed that a concentration of IgE antibodies against
ovomucoid higher than 10.8 kUA/l (positive decision point) indi-
cated a high risk of reacting to heated (as well as raw) egg.7 At the
same time, a concentration below approximately 1 kUA/l (negative
decision point) means there is a low risk of reaction to heated egg,
although the patient may well react to raw egg.
Benhamou Senouf et al. have recently shown in a similar study
but with different patients' characteristics, a cut-off value forTable 1
Clinical characteristics of food allergen components (egg, milk, and wheat).
Antigen Component to food allergens Author Published year R
Egg Gal d 1 (ovomucoid) Ando et al. 2008 O
Ohtani et al. 2015 H
Benhamou et al. 2015 O
f
Gal d 2 (ovalbumin) Benhamou et al. 2015 O
Milk Bos d 4 (alpha-lactoglobulin)
Bos d 5 (beta-lactoglobulin)
Bos d 8 (caseins)
Ahrens et al. 2012 L
p
Kuitinen et al. 2015 H
le
Bos d 8 (caseins) Boyano-Martínez et al. 2009 H
Caubet et al. 2013 C
Yanagida et al. 2015 C
Wheat Gliadin Kotaniemi-Syrj€anen et al. 2010 h
a
Omega-5 gliadin Ebisawa et al. 2011 O
a
Nilsson et al. 2015 H
d
Omega-5 gliadin
HMW-glutenin
Morita et al. 2009 O
Lipid transfer protein (LTP) Palacin et al. 2007 W
Alpha-amylase inhibitors Pastorello et al. 2007 A
imovomucoid of 6.9 kUA/L with a 95% speciﬁcity.8 Also, they were able
to show that a cut-off of 4.1 kUA/L can be used for egg white in order
to distinguish between allergy to all forms of egg, and sensitization
in absence of allergy.
Similarly, the heat-labile egg white allergen ovalbumin can help
distinguishing between various patterns of clinical reactivity to
egg.9
Sequential IgE testing starting with egg white, followed by
ovomucoid, will signiﬁcantly increase the sensitivity of diagnostic
testing compared to testing egg white only, although with a
decrease in speciﬁcity.8
Wright et al. tried to identify the component as potential bio-
markers of sustained unresponsiveness in oral immunotherapy andesults Ref #
VM-sIgE was a good marker for reacting to heated egg. 7
igh levels of OVM-sIgE was associated with persistent egg allergy 6
VM was best to distinguish between allergy to raw only, and allergy to all
orms of egg.
8
VA was the best test for the diagnosis of allergy to raw and cooked egg 8
ow levels of IgE to milk allergen components (casein, Bos d 4, Bos d 5)
redicted outgrowth of milk allergy
16
igh baseline IgE levels to milk components (casein, Bos d 4, Bos d 5) predict
ss successful milk oral immunotherapy
20
igh levels of casein-sIgE was associated with persistent milk allergy 14
asein-sIgE predict clinical reactivity to baked milk 19
asein-sIgE were signiﬁcantly reduced during low-dose-induction OIT 21
igh levels of IgE to gliadins was correlated with persistent wheat allergy
nd the development of asthma in children
33
mega-5 gliadin was useful diagnostic marker in immediate type of wheat
llergy
38
igh levels of omega-5 gliadin-sIgE was associated with severity of reaction
uring wheat challenge
31
mega-5 gliadin and HMW-glutenin were causative antigens in WDEIA 34
heat lipid transfer protein was assosiated with Baker's asthma 44
lpha-amylase inhibitors and lipid transfer protein were associated with
mediate type of wheat allergy
46
Fig. 2. Changes in the levels of egg white- and ovomucoid-speciﬁc IgE among phenotypes of hen's egg allergy with aging. Left side is egg white-speciﬁc IgE (n ¼ 226), right side is
ovomucoid-speciﬁc IgE (n ¼ 226). Solid circles represent <3 years group, solid squares represent 3e6 years group and ﬁlled triangles represent allergic group. Data are shown as the
mean ± standard error of the mean (SEM). The Kruskale Wallis test was used for comparisons among the three groups. A p-value of <0.05 was considered statistically signiﬁcant.
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ated with sustained unresponsiveness.9
We conclude that the use of egg white components is clinically
helpful for distinguishing between sensitization and clinical allergy.
Furthermore, it is helpful for distinguishing between allergy to
cooked and raw egg, or exclusively to raw egg.Milk (Table 1)
Cow's milk proteins are among the most common causes of IgE-
mediated food allergic reactions in children.10 Proteins in cow's
milk have a high sequence homology (>80%) with milk proteins
from goat and sheep and are highly clinically cross-reactive (>90%)
with these species. In contrast, the laboratory and clinical cross-
reactivity is low with milk from donkey, mare, buffalo or camel.11
The majority of patients allergic to milk are sensitized to several
cow's milk proteins. However, the proﬁle of the IgE response to
these components varies greatly. The most important allergens in
milk are caseins (Bos d 8), b-lactoglobulin (Bos d 5), and a-lacto-
globulin (Bos d 4), although allergies to other minor proteins such
as bovine serum albumin (Bos d 6) have also been reported.12Whey
is a mixture of Bos d 5, Bos d 4, Bos d 6, and immunoglobulins,
which are soluble in their native forms, more sensitive to heating
and lose their IgE binding following 15e20 min of boiling at
>90 C.13 Bos d 6 is independent of other cow's milk proteins and
may reﬂect cross-reactivity with beef. Homologs of all of allergens
present in cow's milk are also present in human breast milk, with
the exception of Bos d 5.
CRD can be useful for monitoring natural tolerance develop-
ment in cow's milk allergy. Boyano-Martínez and co-workers have
been following children with cow's milk allergy over time.14 They
have observed that casein is the protein that best discriminates
between persistent and transient allergy. Lower serum levels of IgE
to caseinwere associated with higher chances of resolution of CMA.Ito et al. have found that high levels of casein-speciﬁc IgE antibodies
are strongly associated with milk allergy in children and might be
associated with prolonged allergy.15 Ahrens et al. have shown that
children with lower levels of IgE to cow's milk, Bos d 4, Bos d 5,
kappa-casein, and alpha s1 casein had better odds of outgrowing
their cow's milk allergy over an 80 month period.16
Nowak-Wegrzyn et al. reported that the majority (75%) of the
cow's milk allergic children tolerate cow's milk as an ingredient in
the baked products17,18 and Caubert et al. has found that high levels
of IgE antibodies to casein were predictive of clinical reactivity to
baked milk.19
A treatment option for persistent cow's milk allergy is oral-,
sublingual-, and epicutaneous-immunotherapy. Not all patients
develop tolerance during therapy, and markers to identify those
who will beneﬁt from it are needed. Kuitinen et al. have found that
high baseline IgE levels to a-lactalbumin, b-lactoglobulin and
casein are associated with lower maintenance dose reached.20 An
increase in the IgG4 concentration to milk components during
treatment indicated effective desensitization. Yanagida et al. per-
formed a low-dose-induction OIT for milk in a high risk population
known to have had severe reactions to very low amounts of milk.21
Despite the low levels of intake, casein-speciﬁc IgE levels were
signiﬁcantly reduced. They also found that the casein-speciﬁc IgG4
levels were signiﬁcantly elevated as an indicator of tolerance
induction.
CRD can be helpful for the clinicians when evaluating their
cow's milk allergy patients for monitoring and predicting the res-
olution of the disease. It might also be useful as markers to identify
those who will best beneﬁt from oral immunotherapy.Wheat (Table 1)
Wheat allergy is worldwide common and varies depending on
age and region from 0.4% to 4%.22,23 Sensitization to wheat among
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number of studies in different geographical regions.24 However, the
sensitization rates seem to vary a lot. Venter et al. described a
sensitization rate for wheat of 0.4% in six-year-old children in
Britain.25 €Ostblom et al. found a corresponding rate of 6% among 8-
year old children in Sweden.23 Patelis et al. found a prevalence of
18% among young asthmatics in Sweden.26 This variation is due to
geographical location, selection of study population, and cross-
reactions to pollen. A recent study of 108 atopic Finnish children
demonstrated that a wheat IgE of 10.5 kUA/L had a 72% PPV of
wheat allergy.27 Additionally, younger children may react at lower
wheat IgE-level compared to older children.28 One factor that
contributes to the decreased speciﬁcity of IgE wheat testing is
cross-reactivity between grass pollen and wheat; thus often grass
pollen allergic but wheat tolerant individuals may have elevated
wheat IgE levels.29 Venter et al. has recently demonstrated very low
prevalence of IgE-mediated wheat allergy and high levels of cross-
sensitization between grass and wheat in the Isle of Wight cohort
using CRD.30
This is well noticed in the clinic since a positive test result to
wheat-ﬂour extract may not always correlate with clinical symp-
toms of wheat allergy. This is likely to cause problem with over-
diagnosis of wheat allergy. Nilsson et al. recently described that
only half of the children with a doctor's diagnosis of wheat allergy,
conﬁrmed sensitization to wheat and on a wheat elimination diet,
reacted in oral wheat challenges.31 These patients are unnecessarily
on a wheat-free diet most likely due to tolerance development or
misinterpretation of wheat allergy tests.
This indicates that in vitro diagnosis of allergy to wheat may be
improved by using wheat allergen components.
A child with wheat allergy is likely to become tolerant with a
similar pattern to that of milk or egg allergy. Studies of the natural
history of wheat allergy indicate that high levels of wheat-speciﬁc
IgE predict slower resolution. Keet et al. also were able to show that
children with IgE negative wheat allergy were clinically tolerant by
age three.32 CRD can also be helpful in predicting toleranceTable 2
Clinical characteristics of food allergen components (soybean and peanut).
Antigen Component to food allergens Author Published year R
Soybean Gly m 4 (Bet v 1 homolog) Fukutomi et al. 2012 H
Berneder et al. 2013 G
re
Gly m 5 (7S Globulin)
Gly m 6 (11S Globulin)
Holzhauser et al. 2009 G
s
Ito et al. 2011
Gly m 8 (2S albumin) Ebisawa et al. 2013 G
Klemans et al. 2013
Kattan et al. 2015
Peanuts Ara h 1 (7S globulin)
Ara h 2 (2S albumin)
Ara h 3 (11S globulin)
Lieberman et al. 2013 A
Ara h 2 (2S albumin) Ebisawa et al. 2012 A
Dang et al. 2012
Lieberman et al. 2013
Klemans et al. 2013
Eller et al. 2013
Beyer et al. 2015 A
2
Ara h 2 (2S albumin)
Ara h 6 (2S albumin)
Klemans et al. 2013 T
s
Kukkonen et al. 2015 C
to
Ara h 8 (Bet v 1 homolog) Sicherer et al. 2013 A
Ara h 8 (Bet v 1 homolog)
Ara h 9 (LTP)
Ballmer-Weber et al. 2015 A
E
Ara h 9 (LTP) Sicherer et al. 2013 A
pdevelopment because high IgE levels to gliadins have been show to
correlate with persistent wheat hypersensitivity and the develop-
ment of asthma in children.33
The best-characterized single component of wheat is omega-5
gliadin. It is also the most well-documented of the wheat compo-
nents in WDEIA and IgE-mediated form of food allergy to
wheat.29,34e42 Two studies have also documented that there is an
association between the levels of IgE to omega-5 gliadin and
severity of reaction during wheat challenge.31,37
Many wheat-allergic individuals have been shown also to be
sensitized to a-, b-, and/or g-gliadins as well as high and low mo-
lecular weight glutenins (HMW-glutenin and LMW-glutenin,
respectively).27,31,34,43
Alpha-amylase inhibitors and lipid transfer proteins have been
associated with Baker's asthma and wheat allergy27,44,45 and chal-
lenge proven wheat allergy.46 A new form of wheat-related allergic
disease which seems IgE-mediated is contact urticaria caused by
hydrolyzed wheat protein.47 Nilsson et al. found that majority (96%)
of children with IgE-Ab to wheat had also IgE-Ab to hydrolyzed
wheat protein.48
It seems that a combination of gluten-derived components tests
improves the prediction of clinical reactions both for the diagnosis
of WDEIA and immediate reactions to wheat. There are so far no
commercially available IgE tests for a-, b- or g-gliadins, HMW or
LMW-glutenin.
Soy (Table 2)
Soybean is an important allergen source due to the common use
in processed foods, sometimes representing a hidden allergen.
Fermented soy products such as soy sauce and miso are much less
allergenic compared with soy milk and tofu. Allergenic reactions
have been described after exposure to both highly processed soy as
well as unprocessed soy beans.49
Soybean allergy in children is known to be mediated primarily
by contact via the gastrointestinal tract, often in the form of soya-esults Ref#
igh level of Gly m 4-sIgE was associated with adult soybean allergy 58
ly m 4 was a risk factor for severe oral allergy syndrome or systemic
actions to soybean in patients allergic to birch
60
ly m 5 or Gly m 6 were diagnostic markers for severe allergic reactions to
oy
50
51
ly m 8 was the best diagnostic marker for soybean allergy 52
53
54
ra h 1, 3 and 2 were associated with severe reactions to peanut 65
ra h 2 was the best diagnostic marker for peanut allergy 64
66
65
68
72
95% probability for a positive peanut challenge was estimated for an Ara h
sIgE of 42.5 kU/L
78
he diagnostic value of sIgE to Ara h 6 on population level was as good as
IgE to Ara h 2
68
o-sensitization to Ara h 2 and Ara h 6 was associated with severe reactions
peanut
73
ra h 8 was associated with no or very mild local symptoms 70
ra h 8 and Ara h 9 were major allergens for central/western and southern
uropeans
71
ra h 9 was associated with mild to severe symptoms in Mediterranean
atients
70
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cow's milk. The primary sensitizers seem to be the most important
soya proteins Gly m 5 (7S Globulin), Gly m 6 (11S Globulin) and Gly
m 8 (2S albumin).50e54 The latter protein has recently been iden-
tiﬁed as amajor relevant allergenic molecule and ofﬁcially accepted
by the IUIS Allergen Nomenclature Sub-Committee. Ebisawa et al.
studied soy sensitization in symptomatic and non-symptomatic
children on ingestion of soy and found that Gly m 8 is a major
allergen in soy allergic children.52 Klemans et al. studied adult pa-
tients with suspected soy allergy and found that Gly m 8 sIgE had
the greatest accuracy in the diagnosis of soy allergy.53 Kattan et al.
was also able to verify that clinical reactivity to soy is best identiﬁed
by component testing to Gly m 8.54
Since the turn of the century, allergic reactions to moderately
processed soy powder have increasingly been recognized among
birch pollen allergic individuals. This form of soy allergy may be
acquired following primary sensitization to birch pollen, due to IgE
cross-reactivity between the most important birch pollen allergen
Bet v 1 and its homologous protein in soybean, Glym 4.55 Glym 4 is
underrepresented in diagnostic soybean extracts leading to vast
differences between extract and component IgE tests. Recent data
fromGermany show that soy sensitization can be as prevalent as six
percent in a normal population based on large cohort of approx.
13,000 individuals aged 3e17 years of age.56 This is mostly like due
to high prevalence of birch sensitization. Haftenberger et al. have
recently shown that prevalence of Glym 4 sensitizationwas as high
as 10.3% and to soybean extract 3.7% in a similar adult cohort with
approx. 7000 individuals.57
Unlike the other Bet v 1 homolog Gly m 4 has been shown to
be a risk factor for severe oral allergy syndrome or systemic re-
actions to soy in patients allergic to birch.58e60 Fukutomi et al.
have studied the clinical impact of respiratory sensitization to
pollen-derived pathogenesis-related class 10 protein on the
development of adult soybean allergy.58 They found that soy milk
was the allergen that most prevalently induced symptoms in
those who had been exposed, whereas none of the soybean-
allergic patients reacted to fermented soybean products. The
explanation is that Gly m 4 is heat-labile to a degree but also
apparently susceptible to degradation by fermentation. This con-
dition is also present in children and Kosma et al. reported similar
clinical picture in children allergic to birch pollen.59 The children
also experienced severe allergic reactions following ingestion of
soy milk during the pollen season. Berneder et al. reported
recently Gly m 4 as a marker for severe food allergic reactions to
soy.60 Klemans et al. reported that subjects who only reacted to
soy milk, but tolerated other forms of soy, had signiﬁcantly higher
sIgE levels to Gly m 4.53
Severe reaction to soy allergens can be caused by a primary soy
allergy as well as to birch pollen e related soy allergy. In the ﬁrst
case, it is important that the patient avoid allergenic soy products
and carry an emergency kit. In the second case, the patient needs
only to avoid soy products that have not been extensively pro-
cessed. Component testing for soy can help differentiate between
these two conditions.49
Peanut (Table 2)
The best documented CRD area regarding clinical utility of
measuring IgE is peanut components. The reason for this might be
that peanut allergy is major public health problem and is known to
be over diagnosed due to its cross-reactivity. For example,
approximately 8% of the US population test positive for peanut but
clearly the vast majority of these individuals tolerate this food61
CRD studies have been carried out at all continents with similar
results.62e66Klemans et al. recently systematically searched the literature to
assess the diagnostic value of sIgE to peanut components in diag-
nosing peanut allergy.67 Data on sensitivity, speciﬁcity, and positive
and negative likelihood ratios were extracted or calculated for a
descriptive analysis and they found twenty-two studies eligible for
inclusion.
Speciﬁc IgE to Ara h 2 (2S albumin) showed the best diagnostic
accuracy of all tests for peanut allergy. Compared to the currently
used SPT and sIgE to peanut extract, sIgE to Ara h 2 was superior in
diagnosing peanut allergy and the authors suggest that the peanut
extract-based tests should be replaced in daily clinical practice,
especially in children. Sensitization to Ara h 1 (7S globulin), 3 (11S
globulin) and 2 (2S albumin) have also been associated with severe
reactions.65,66,68,69 Sensitization to Ara h 9 (LTP) has been associ-
ated with mild to severe symptoms in Mediterranean patients and
sensitiztion to Ara h 8 (Bet v 1 homolog) with no or very mild local
symptoms.70
Areas that are recently in focus for peanut CRD studies are
whether the concentration of IgE antibodies to Ara h 2 is associated
with severity of symptoms upon peanut ingestion.
Ballmer-Weber et al. found that IgE to Ara h 2  1.0 kUA/l is
signiﬁcantly associated with the development of systemic re-
actions to peanut in the Europrevall study.71 Klemans et al. found
that higher levels of sIgE to Ara h 2 and peanut extract were
associated with a larger proportion of patient groups reacting to a
dose increase with objective symptoms in both adults and chil-
dren.68 Eller and Bindslev-Jensen documented that symptom
severity elicited during challenge correlated signiﬁcantly with the
levels of Ara h 2 (r(s) ¼ 0.60, P < 0.0001), but large individual
variation was found.72
Kukkonen et al.were able to show that co-sensitization to Ara h
2 and Ara h 6 was associated with severe reactions distinguishing
severe allergy from mild symptoms.73 This ﬁnding is in line with a
number of studies suggesting that severity correlates with binding
to multiple proteins, Ara h 1e3.74e77 Also Klemans et al. were able
to verify the clinical utility of measuring IgE to Ara h 6 in adults.68
The diagnostic value of sIgE to Ara h 6 on population level was as
good as sIgE to Ara h 2. On individual level, however, 5% of the
subjects showed contradicting results between both tests, leading
to a risk of misdiagnosis if only one of both tests is used. It therefore
seems that also Ara h 6 should be used in the clinic in order to
optimize the diagnostic work-up.
Despite the consistent ﬁnding of Ara h 2 as the best available
predictor of peanut allergy, no universal sIgE cut-off level has been
established as predictive of clinical reactivity. Recently Beyer et al.
published a 95% probability for a positive peanut challenge was
estimated for an Ara h 2 sIgE as high as 42.5 kUA/L.78 The range of
cut-offs proposed is most likely due to variations in geographic
location and patient selection criteria.
CRD has also started to be used in oral immunotherapy in pea-
nut allergic patients. Vickery et al. found that lower baseline levels
of IgE to Ara h 2, Ara h 3 and peanut were associatedwith successful
desensitization.79 Also studies from Japan have shown that Ara h 2
speciﬁc antibodies seem to dominate the temporary IgE and sus-
tained IgG4 response during OIT treatment.80
Recent ﬁndings in processing of peanuts have brought light
upon the issue of allergenicity which is of importance for the
peanut allergic individual. Roasting at high temperatures likely
promotes the formation of compact globular protein aggregates
that can increase allergenicity of Ara h 1 and 2, whereas cooking
might reduce their allergenicity. Peanut oil is commonly used and
in its unreﬁned form, may contain sufﬁcient amounts of allergens
to trigger reactions. Petersen et al. could demonstrate that roasting
modiﬁes the Ara h 8 molecule and increases the IgE reactivity as
well as thermal and proteolytic stability.81
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In epidemiology of tree nut allergy, clear geographical patterns
are found. In most studies, estimates of the prevalence of tree nut
allergies are based on sensitization and/or a convincing history. The
prevalence rates are rarely based on a standardized food challenge
which explains the large heterogeneity of published prevalence
data.
A recent meta-analysis has shown that in continental Europe,
the most prevalent tree nut allergy is to hazelnut.82 Walnut and
cashew allergies are the most common tree nut allergies in the
USA, while Brazil nut and walnut allergy were among the most
frequent nut allergies in the UK. Imamura et al. have shown in
Japan that walnut was the most common tree nut causing
anaphylaxis.83 Johnson et al. reviewed emergency visits during
the ﬁrst decade of 2000 and found that peanuts and tree nuts
accounted for 50% of the food allergy emergency incidents.84
They were able to show that the number of cashew nut re-
actions increased signiﬁcantly over the study period whereas the
number of reactions to peanut and other tree nuts remained
constant.
Hazelnut has been shown to be the most prevalent food sensi-
tization in the adult EuroPrevall cohort at 9.3%, with a large varia-
tion between the European countries (lowest Iceland 1.3% and
highest Switzerland 17.8%).85 Sensitization to hazelnut is more
common in northern Europe and can be explained by extensive
cross-reactivity to birch pollen but also to other tree nuts. Hazelnut
allergy is the tree nut allergy that has been most extensively
studied using CRD. There are several relevant allergens in hazel-
nuts. Cor a 1 is a homolog of the major birch pollen Bet v 1. Cor a 8 is
lipid transfer protein. Cor a 9, an 11S globulin- and Cor a 14 is a 2S
albumin seed storage protein.
Recent studies in the USA and Europe have demonstrated an
important role for Cor a 9 and Cor a 14 in predicting clinical reac-
tivity to hazelnut.78,86e91 A Dutch study by Masthoff et al. were the
ﬁrst to describe the clinical utility of combining IgE tests for Cor a 9
with Cor a 14.86 Sensitization to Cor a 9, Cor a 14, or both was
strongly associatedwith having objective symptoms on ingestion of
hazelnut. In children, sIgE levels to Cor a 9 of1 kUA/L or Cor a 14 of
5 kUA/L, and, in adults, sIgE levels to Cor a 9 of1 kUA/L or Cor a 14
of 1 kUA/L had a speciﬁcity of >90% and accounted for 83% of
children and 44% of adults with hazelnut allergy with objective
symptoms. Brandstr€om et al. showed in their DBPCFC study that
children positive in challenge also had higher levels of IgE-ab to Cor
a 9 and Cor a 14 (P < 0.01 and P < 0.001, respectively) compared
with those with a negative challenge.87 In a US cohort, Kattan et al.
reported that a sIgE result 2.0 kUA/L for Cor a 9 or 1.0 kUA/L for
Cor a 14 had a sensitivity of 92% and speciﬁcity of 93% for clinical
reactivity.89Table 3
Clinical characteristics of food allergen components (tree nuts, sesame, and buckwheat).
Antigen Component to food allergens Author Published year
Hazelnut Cor a 9 (11S globulin)
Cor a 14 (2S albumin)
Masthoff et al. 2013
Kattan et al. 2014
Beyer et al. 2015
Brandstr€om et al. 2015
Buyuktiryaki et al. 2016
Cor a 14 (2S albumin) Carraro et al. 2016
Eller et al. 2016
Cashew nut Ana o 3 (2S albumin) Savvatianos et al. 2015
Walnut Jug r 1 (2S albumin) Sordet et al. 2009
Brazil nut Ber e 1 (2S albumin) Rayes et al. 2015
Sesame Ses i 1 (2S albumin) Maruyama et al. 2016
Buckwheat Fag e 3 (7S globulin) Maruyama et al. 2016In a recent German multicenter study, Beyer et al. evaluated 143
children with suspected hazelnut allergy.78 All children underwent
an OFC to hazelnut, and sIgE to whole hazelnut and Cor a 1, Cor a 8,
Cor a 9, and Cor a 14were analyzed.With an AUC of 0.89, sIgE to Cor
a 14 was found to distinguish between allergic and tolerant chil-
dren better than sIgE to whole hazelnut (AUC 0.71, p < 0.001). The
AUC for Cor a 9 was 0.80. A Cor a 14 level of 0.35 kUA/L was found to
reach a sensitivity of 85% and a speciﬁcity of 81%, with a 90%
probability of reaction found at 47.8 kUA/L.
Hazelnut component testing to Cor a 9 and Cor a 14 has
demonstrated improved utility in differentiating patients with
birch pollen sensitization who are not clinically reactive or have
mild oral symptoms from those more likely to have severe allergic
reactions. These tests show greater speciﬁcity than traditional SPT
and sIgE to hazelnut extract, though it is difﬁcult to determine
diagnostic cut-off values as predictive sIgE levels vary among the
different studies.
Cashew is now used in industrial food as replacement for
more expensive pine nuts and for its properties of improving
texture. Reactions to cashew nuts are as common as reactions to
milk and egg in early life in Sweden92 and is associated with an
equivalent or even greater risk for anaphylaxis than peanuts in
children.93,94
Savvatianos et al. have studied sensitization to cashew nut 2S
albumin, Ana o 3, and found it to be highly predictive of cashew and
pistachio allergy in Greek children.95 IgE sensitization to rAna o 3
(0.35 kUA/L) was detected in 93 of the allergic children (93%). In
contrast, only 2 (6%) of the tolerant patients were found to be
positive to rAna o 3.
The molecular components identiﬁed and recognized as aller-
gens in English walnut, Juglans regia, are Jug r 1, Jug r 2, and Jug r 3,
Jug r 4.96,97 Jug r 1 is a 2S albumin seed storage protein and is
inherently allergenic. Jug r 2 is a vicilin storage protein and is
thought to have low clinical signiﬁcance. Jug r 3, a commonly
recognized lipid transfer protein (LTP), is associated with local
symptoms and systemic reactions. Jug r 1, Jug r 2 and Jug r 3 are
commercially available walnut components. Ciprandi et al. have
shown that high levels of IgE to rawwalnut and positivity to Jug r 1,
2, and 3, mainly if multiple, may be considered marker of severe
walnut allergy.98 Rayes et al. have studied Brazil nut allergy and
found sIgE to recombinant allergen component Ber e 1may provide
higher sensitivity than whole Brazil nut extract.99 They acknowl-
edge that the use of a combination of SPT and sIgE to Ber e 1 might
further enhance the diagnostic accuracy and reduce the need for
oral challenge for the diagnosis of Brazil nut allergy. Goikoetxea
et al. have studied if microarray analysis is useful and sufﬁcient to
diagnose nut allergy in the Mediterranean area.100 They found that
the diagnostic performance of ISAC was adequate for hazelnut and
walnut allergy.Results Ref#
Cor a 9 and Cor a 14 were predicting clinical reactivity to hazelnut 86
90
78
87
89
Cor a 14 was predicting clinical reactivity to hazelnut 91
88
Ana o 3 was highly predictive of cashew and pistachio allergy 95
Jug r 1 was inherently allergenic 97
Ber e 1 predicted clinical reactivity to Brazil nut 99
Ses i 1 was the best diagnostic marker for sesame allergy 104
Fag e 3 -sIgE improved the diagnostic accuracy for buckwheat allergy 108
M.P. Borres et al. / Allergology International 65 (2016) 378e387384Sesame and buckwheat allergy (Table 3)
Sesame is themost prevalent cause of allergic reactions to seeds.
Sesame allergy is an increasingly recognized health burden, espe-
cially in developed countries including European countries, United
States, and Japan.101 Most cases occur in infancy and early child-
hood and the clinical presentation includes signiﬁcant numbers of
patients with severe reactions.83 Sesame is a potent allergen and
anaphylaxis has been reported in up to 30% of sesame-allergic
children. Sesame allergy is also present in adults and can be pre-
ceded by de novo sensitization. The gold standard of objective ev-
idence, that is assessment of sensitization and oral food challenge
(OFC) have been used in few sesame studies.101 The prevalence of
sesame allergy seems to differ between communities due to
different food habits. Sesame allergy was reported to be the third
most common allergy in Israeli children, exceeded only bymilk and
egg allergy.102 The speciﬁc IgE tests and skin prick tests presently
available for diagnosis of sesame allergy are all based on natural
sesame extract. Seven sesame allergen components have been
registered by theWHO/IUIS Allergen Nomenclature Subcommittee,
including two 2S albumins (Ses i 1 and Ses i 2), one vicilin-like 7S
globulin (Ses i 3), two oleosins (Ses i 4 and 5), and ﬁnally two 11S
globulins (Ses i 6 and Ses i 7). The 2S albumins and 11S globulins are
dominating seed storage proteins in sesame, whereas 7S globulin is
a minor component (Fig. 3). All together, they represent 80e90% of
the total sesame seed proteins.103
Maruyama et al. studied almost one hundred Japanese children
sensitized to sesame and diagnosed their sesame allergy through
OFC or a convincing history.104 Recombinant Ses i 1 was shown to
have the best diagnostic performance of the allergen components
based on area under curve (AUC) values from receiver operating
characteristic (ROC) analysis. The experimental rSes i 1 Immuno-
CAP test had larger AUC (0.891; 95% CI, 0.826e0.955) compared to
the commercially available sesame test (0.697; 95% CI,
0.589e0.805). The clinical sensitivity and speciﬁcity for the rSes i 1
ImmunoCAP test at optimal cut-off (3.96 kUA/L) were 86.1% and
85.7%, respectively.
Buckwheat is one of the leading causes of food anaphylaxis
especially in Japan and Korea, even though buckwheat sensitization
and allergy has a low prevalence.105e107 Buckwheat allergy nor-
mally develops during school age or later, unlike allergies caused by
eggs and dairy products that occur during early childhood. ThisFig. 3. Sesame seed extract and recombinant Ses i 1. The molecular size of sesame 2S
albumin is smaller than that of recombinant Ses i 1 (rSes i 1) under the reducing
condition on SDS-PAGE, because 2S albumin is processed into the subunits.might be because families introduce buckwheat late into the diet
compared to egg and milk. The prevalence of buckwheat allergy in
Japanese and Korean schoolchildren is estimated to be 0.1%e
0.2%.106,107 If buckwheat allergy is suspected, food avoidance is
often initiated without performing OFCs, owing to the high risk of
anaphylaxis. Therefore, there is a need among clinicians to identify
the allergen components associated with symptomatic buckwheat
allergy. Reported buckwheat allergen components of importance
include Fag e 1 (13S globulin), Fag e 2 (2S albumin), Fag e 3 (7S
globulin) and Fag e 10 kD (2S albumin).105
Maruyama et al. recently examined sixty-ﬁve children with
suspected buckwheat allergy.108 They were divided into two groups
according to their clinical reactivity to buckwheat based on chal-
lenge outcome and/or clinical history. The symptomatic group
comprised subjects with a positive challenge result (n ¼ 21) and
subjects with a convincing history of buckwheat allergy (n ¼ 7),
among which 4 subjects previously experienced anaphylactic
symptoms. The authors found that measurement of sIgE antibodies
to Fag e 3 improved the diagnostic accuracy owing to a signiﬁcantly
higher clinical speciﬁcity than that achieved withmeasuring sIgE to
buckwheat.Clinical conditions when CRD is relevant for the food allergic
patients
The ﬁrst line approach to the diagnosis of food allergy is a
thorough clinical history and physical examination of the patient.
Sensitization to a food allergen can be conﬁrmed with an allergen
extract-based in vitro test or an in vivo skin prick test. However, an
increasing proportion of patients have inconclusive clinical history,
symptoms proﬁles and allergen extract test results. In many cases,
such ambiguities may be resolved by including CRD to the diag-
nostic workup.1
CRD can contribute to efﬁcient identiﬁcation of primary sensi-
tization to symptom-eliciting allergens and reveal co-sensitization
and/or cross-sensitization. Using IgE testing with a microarray
assay in a retrospectively study of 74 patient cases, Cardona and
colleagues observed that underlying sensitizations to plant-derived
foods, mainly vegetables and cereals, accounted for the reactions in
92% of patients sensitized to LTPs (Pru p 3).109
Further, molecular testing can be used to characterize the
severity and assess the future risk of a reaction as have been dis-
cussed in the allergen sections above. CRD can also be helpful when
there is co-sensitization to inhalant and food allergens and the
symptomology is unclear. Pascal et al. studied Spanish patients with
a complex clinical history andmultiple sensitizations to plant-foods
and pollens and could demonstrate that a broad spectrum of clin-
ical reactions can be explained by LTP sensitizations using a
microarray test.110 Romano et al. found that LTP was the most
frequent sensitizer in Italian subjects with food-dependent exer-
cise-induced anaphylaxis.111
CRD can be used to optimize the decision process of food chal-
lenge tests, avoiding costly, time consuming, and potentially life-
threatening reactions and improve allergen avoidance recom-
mendations. Our personal reﬂection is that CRD allows the clinician
to perform safe challenges. This seems to increase the number of
OFCs, especially for peanut and hazelnut due to the fact that these
allergies are heavily over diagnosed.
When suspecting idiopathic anaphylaxis allergen microarrays
allow the simultaneous detection of patients' antibody proﬁles
towards a large variety of each of the molecular allergens. Heaps
et al. used the microarray and identiﬁed hitherto unknown sensi-
tizations in up to 20% of patients with idiopathic anaphylaxis, that
were highly likely to cause anaphylaxis. In the majority of cases,
M.P. Borres et al. / Allergology International 65 (2016) 378e387 385sensitization to wheat omega-5 gliadin and shrimp components
were demonstrated.112
Conclusion
The use of allergen components is rapidly evolving and in-
creases our possibility to treat food allergic patients with a more
individual approach. Using molecular allergology, we can already
now better diagnose, prognose, and grade the food allergy. We can
also get help in deciding which patient should receive OFC or not.
Daily routine molecular allergy diagnostics offers a number of
beneﬁts that give us a higher diagnostic precision and allow for
better management of the patient.
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